$26.4912
0.1612[0.61%]
Last update: 12:18PM Get Real Time Here
Pacira BioSciences
(NASDAQ:PCRX)Latest News for Pacira BioSciences Stock (NASDAQ:PCRX)
Pacira BioSciences Stock (NASDAQ: PCRX)
Categories: All
Tuesday, April 09, 2024
Wednesday, March 13, 2024
Thursday, March 07, 2024
Monday, March 04, 2024
Friday, March 01, 2024
- Navigating 4 Analyst Ratings For Pacira BioSciencesBenzinga Insights - Mar 1, 2024, 11:00AM
- RBC Capital Maintains Outperform on Pacira BioSciences, Lowers Price Target to $45Benzinga Newsdesk - Mar 1, 2024, 10:35AM
- Needham Reiterates Buy on Pacira BioSciences, Maintains $45 Price TargetBenzinga Newsdesk - Mar 1, 2024, 5:30AM
Thursday, February 29, 2024
- Pacira BioSciences Forecasts 2024 Revenue Of $680M-$705M Versus Consensus Of $716.62M, With Adjusted Gross Margin Of 74%-76%Benzinga Newsdesk - Feb 29, 2024, 8:06AM
- Pacira BioSciences Q4 Adjusted EPS $0.89 Beats $0.88 Estimate, Sales $181.24M Miss $181.66M EstimateBenzinga Newsdesk - Feb 29, 2024, 8:04AM
- Earnings Scheduled For February 29, 2024Benzinga Insights - Feb 29, 2024, 5:15AM
Wednesday, February 28, 2024
Thursday, February 15, 2024
Monday, February 12, 2024
Thursday, February 08, 2024
Thursday, January 04, 2024
Thursday, December 21, 2023
Wednesday, December 20, 2023
Friday, November 10, 2023
Monday, November 06, 2023
Friday, November 03, 2023
- Piper Sandler Maintains Overweight on Pacira BioSciences, Lowers Price Target to $42Benzinga Newsdesk - Nov 3, 2023, 5:12PM
- RBC Capital Maintains Outperform on Pacira BioSciences, Lowers Price Target to $58Benzinga Newsdesk - Nov 3, 2023, 3:15PM
- Needham Maintains Buy on Pacira BioSciences, Lowers Price Target to $45Benzinga Newsdesk - Nov 3, 2023, 6:42AM
Thursday, November 02, 2023
- Pacira BioSciences Lowers FY23 Net Product Sales From $550M-$560M To $530M-$540MBenzinga Newsdesk - Nov 2, 2023, 8:09AM
- Pacira BioSciences Q3 2023 Adj. EPS $0.72 Misses $0.78 Estimate, Revenue $163.9M Misses 173.004M EstimateBenzinga Newsdesk - Nov 2, 2023, 8:05AM
- Earnings Scheduled For November 2, 2023Benzinga Insights - Nov 2, 2023, 4:56AM
Wednesday, November 01, 2023
Monday, October 23, 2023
Thursday, October 12, 2023
- Board Member at Pacira BioSciences Acquires Company Stock Options Worth 30,967 SharesBenzinga Insights - Oct 12, 2023, 11:00AM
- Director at Pacira BioSciences Acquires Company Stock Options Worth 30,967 SharesBenzinga Insights - Oct 12, 2023, 11:00AM
- Pacira BioSciences Director Awarded $933K Worth of Stock OptionsBenzinga Insights - Oct 12, 2023, 11:00AM
Thursday, October 05, 2023
Tuesday, October 03, 2023
Monday, October 02, 2023
Thursday, September 28, 2023
Tuesday, September 26, 2023
Monday, September 11, 2023
Friday, September 08, 2023
Thursday, August 03, 2023
- Piper Sandler Maintains Overweight on Pacira BioSciences, Lowers Price Target to $50Benzinga Newsdesk - Aug 3, 2023, 12:37PM
- Truist Securities Maintains Buy on Pacira BioSciences, Lowers Price Target to $55Benzinga Newsdesk - Aug 3, 2023, 12:10PM
- Benzinga's Top Ratings Upgrades, Downgrades For August 3, 2023Benzinga Insights - Aug 3, 2023, 11:00AM
- RBC Capital Maintains Outperform on Pacira BioSciences, Lowers Price Target to $68Benzinga Newsdesk - Aug 3, 2023, 10:26AM
- 4 Analysts Have This to Say About Pacira BioSciencesBenzinga Insights - Aug 3, 2023, 10:01AM